ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,521Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 29

$493K Total Retail Price of All Prescriptions

Rank: 17 out of 29

402 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 402 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 402 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 9,614 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
FUROSEMIDE 476 451 1 3
LEVOTHYROXINE SODIUM 422 409 2 1
LISINOPRIL 420 414 3 2
AMLODIPINE BESYLATE 353 336 4 5
GABAPENTIN 347 321 5 10
MIRTAZAPINE 287 287 6 13
HYDROCODONE-ACETAMINOPHEN 272 248 S3 7 7
WARFARIN SODIUM 263 240 8 14
CITALOPRAM HBR 261 257 9 11
METOPROLOL TARTRATE 241 228 10 15
POTASSIUM CHLORIDE 240 230 11 6
SIMVASTATIN 236 223 12 4
METFORMIN HCL 180 175 13 19
NAMENDA 157 154 14 12
DONEPEZIL HCL 156 152 15 9
TAMSULOSIN HCL 145 128 16 31
LOSARTAN POTASSIUM 127 127 17 28
OMEPRAZOLE 122 105 18 8
CARVEDILOL 119 108 19 27
ESCITALOPRAM OXALATE 111 110 20 37
ALENDRONATE SODIUM 110 110 21 26
QUETIAPINE FUMARATE 107 105 22 32
METOPROLOL SUCCINATE 106 81 23 16
PREDNISONE 101 95 24 41
DIVALPROEX SODIUM 92 84 25 45
SERTRALINE HCL 92 92 25 17
ALLOPURINOL 89 89 27 40
PRAVASTATIN SODIUM 86 85 28 18
LANTUS SOLOSTAR 84 82 29 92
LANTUS 82 64 30 39
CYMBALTA 80 62 31 29
TRAMADOL HCL 78 63 32 24
ATENOLOL 72 60 33 23
LEVETIRACETAM 71 50 34 77
HYDRALAZINE HCL 68 53 35 56
HALOPERIDOL 68 48 35 146
ATORVASTATIN CALCIUM 68 65 35 25
DIGOXIN 68 68 35 34
ISOSORBIDE DINITRATE 61 55 39 116
DIOVAN 60 60 40 35
RISPERIDONE 58 34 41 49
IPRATROPIUM-ALBUTEROL 58 52 41 58
ADVAIR DISKUS 54 48 43 68
LATANOPROST 50 41 44 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 10, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.